Skip to main
TBI

TrueBlue (TBI) Stock Forecast & Price Target

TrueBlue (TBI) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TrueBlue Inc. reported revenue growth of 2% year-over-year, primarily driven by strong performance in the commercial sector, which exhibited double-digit growth. The company also achieved an improvement in adjusted EBITDA margin, increasing by 50 basis points year-over-year to 0.7%, attributed to effective strategic cost management. Despite missing the midpoint guidance for revenue growth, the underlying strength in key segments and improved margins indicate a positive outlook for the company's financial health.

Bears say

TrueBlue Inc. has experienced a significant decline in its financial performance, notably with an adjusted EBITDA margin that decreased by 320 basis points year-over-year, landing at just 5.2%, which fell short of forecasted expectations due to reduced operating leverage amid declining organic revenues. The company’s PeopleReady segment, which generates the majority of its revenue, reported a 5% year-over-year revenue decrease, surpassing the expected midpoint decline of 3%, indicating persistent weakness across various client verticals. Additionally, TrueBlue recorded an adjusted loss per share of $(0.07) in the second quarter, further emphasizing the challenges the company is facing in maintaining profitability amid these adverse financial trends.

TrueBlue (TBI) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TrueBlue and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TrueBlue (TBI) Forecast

Analysts have given TrueBlue (TBI) a Buy based on their latest research and market trends.

According to 1 analysts, TrueBlue (TBI) has a Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TrueBlue (TBI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.